#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Head and neck cancer Neuronal ceroid lipofuscinosis Cervix carcinoma Penile squamous cell carcinoma Hypophosphatasia Hyperadrenocorticism Osteosarcoma metastatic Hypergammaglobulinaemia benign monoclonal Ewing's sarcoma Acute respiratory distress syndrome Astrocytoma Barth syndrome Immune-mediated myositis Retinal artery occlusion Growth hormone deficiency More trials…

    Learn about Rare Diseases

    Choroid melanoma Retinitis pigmentosa – Trials in Disease Osteosarcoma recurrent – Treatment Marginal zone lymphoma – Life with Disease Wiskott-Aldrich syndrome – Life with Disease VEXAS syndrome – Life with Disease Soft tissue sarcoma – Diagnostics Nephrotic syndrome – Life with Disease Arterial tortuosity syndrome – Treatment Hyperoxaluria – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lurbinectedin Nafarelin Tucatinib Quercus Robur Pollen Extract THEOPHYLLINE ANHYDROUS Galcanezumab Ibuprofen At-1501 Ab-729 Raxtozinameran Ascorbic Acid Bp Bexotegrast Abc-31-116 HLX43 Mk-1167 Tilsotolimod Sodium Lisinopril Dihydrate Tocotrienol Elacestrant Dihydrochloride Tiratricol More therapies…

    Learn about Your Condition

    EGFR gene mutation Vascular graft thrombosis Cervix carcinoma Bacterial infection Lung transplant Craniopharyngioma Hepatic fibrosis Chronic lymphocytic leukaemia Eye pain Venous thrombosis Liposarcoma Anogenital warts Cardiogenic shock Follicular thyroid cancer ROHHAD syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. NZOZ Krak-Medyk Sp. Z o.o

NZOZ Krak-Medyk Sp. Z o.o

Ułanów 29, Cracow, 31455, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of ARO-MUC5AC Inhalation Solution for Patients with Asthma and COPD

    Not recruiting

    1 1
    Investigated Diseases:
    • Asthma
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Ads-013
    Poland Spain

  • Study on the Effects of ARO-RAGE (ADS-015) for Patients with Inflammatory Lung Disease

    Not recruiting

    1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Ads-015
    Poland Spain

  • Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Atuliflapon
    • Salbutamol
    Bulgaria Croatia Germany Hungary The Netherlands Poland +4

  • Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    Bulgaria Czechia Germany Greece Hungary Italy +5

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!